Skip to content

Prospective Hounsfield Unit measurements of intercorporal bone grafts remodelling towards spinal fusion.

Prospective Hounsfield Unit measurements of intercorporal bone grafts remodelling towards spinal fusion. - Intercorporal Bone Graft Measurement Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51679
Enrollment
30
Registered
2022-09-22
Start date
2022-12-12
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Displacement of vertebra in the spine spondylolisthesis

Interventions

None listed

Sponsors

Rijnstate Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients are only eligible for participation if they i) were non-responsive to non-operative treatment in the six months prior to study enrolment, ii) have fusion indicated for only one segment in the L1 to S1/ilium region and iii) are between the age of 45 and 80.

Exclusion criteria

Exclusion criteria: Patients will be excluded from participation if they i) will receive revision spine surgery, ii) do not want to provide informed consent or when iii) pregnant or expecting to be pregnant within in the next two years.

Design outcomes

Primary

MeasureTime frame
The main outcome of interest will be the participants* individual and group (mean, SD) Hounsfield Unit values of their intercorporal bone graft(s) as calculated from their (four) CT-scans. We will use the standardized HU measurement protocol developed during a feasibility study. The HU will be assessed independently by three observers.

Secondary

MeasureTime frame
Secondary outcomes include the Oswestry Low Back Pain Disability Questionnaire (ODI), Research and Development 36 (RAND-36), Visual Analogue Scale (VAS) for back and leg pain and the intercorporal fusion result criteria by Brantigan et al.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)